Al's Comment:

Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database         One of the key findings is that only 42% of the elderly patients in the USA with Glioblastoma used any chemotherapy compared to 63% of younger people. Same problem with radiation and surgery, all 3 of which were shown to increase survival time if used.   They found the average survival time was only 9.1 months. We need to figure out why these people did not receive treatment.  Cost may be a factor.  The first Temodar prescription usually costs in the neighborhood of $8,000 with a Medicare copayment of about $1,000. Many people refuse to buy the Temodar due to the cost. The manufacturer of Temodar closed their assistance program a long time ago and right now we - the Musella Foundation - are the only copayment assistance program open that can help Medicare patients with their copayment for Temodar (and Optune and Avastin). (Others open and close but none are open now).  We helped over 1,500 patients pay for the medications they need. I am sure this has helped these people live longer. Having said that, we need to change the laws so people who have health insurance do not have to go without medicines due to their cost.


Posted on: 01/23/2021

Outcomes and Patterns of Care in Elderly Glioblastoma Multiforme Patients: A Population-Based Study of the National Cancer Database

 


Click HERE to return to brain tumor news headlines.